Product Name :
Macitentan/Tadalafil
Search keywords :
3′,5′-Cyclic nucleotide phosphodiesterase
drugId :
null
Target Vo:
Phosphodiesterase 5A
Target Vo Short Name :
PDE5A
Moa_Name:
Phosphodiesterase 5A inhibitors
First Approval Country :
United States
First Approval Date Filter:
2024
Origin Company_Name :
Actelion Pharmaceuticals Ltd
Active Company_Name :
Actelion Pharmaceuticals Ltd
Active Indication_Name:
Pulmonary Arterial Hypertension
In Active Indication_Name:
Termination Status :
China Termination Status :
Highest Status:
Approved
China Highest Status:
Phase 3 Clinical
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tabalumab Technical Information
Ki-67 Antibody custom synthesis
phospho-PI3 Kinase p110 beta (Ser1070) Antibody: phospho-PI3 Kinase p110 beta (Ser1070) Antibody is an unconjugated, approximately 110-123 kDa, rabbit-derived, anti-phospho-PI3 Kinase p110 beta (Ser1070) polyclonal antibody. phospho-PI3 Kinase p110 beta (Ser1070) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, guinea pig background without labeling.